deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT03363165

Hepatocyte Growth Factor to Improve Functioning in PAD (HI-PAD)

Hepatocyte Growth Factor to Improve Functioning in Peripheral Artery Disease: The HI-PAD Study

Sponsor: Helixmith Co., Ltd.

Conditions Peripheral Artery Disease
Interventions Placebo VM202
Updated 17 times since 2017 Last updated: May 2, 2024 Started: Jan 1, 2018 Primary completion: Feb 10, 2023 Completion: Sep 5, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Peripheral Artery Disease and is currently completed. Helixmith Co., Ltd. leads this study, which shows 17 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Dec 2017 – ~Feb 2018 · 2 months · monthly snapshot~Feb 2018 – ~Apr 2018 · 59 days · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshot~Dec 2018 – ~Jun 2019 · 6 months · monthly snapshot~Jun 2019 – ~Sep 2019 · 3 months · monthly snapshot~Sep 2019 – ~Aug 2020 · 11 months · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~May 2022 · 13 months · monthly snapshot~May 2022 – ~Feb 2023 · 9 months · monthly snapshot~Feb 2023 – ~May 2023 · 3 months · monthly snapshot~May 2023 – ~Dec 2023 · 7 months · monthly snapshot~Dec 2023 – ~Jun 2024 · 6 months · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

17 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jun 2024 — Jul 2024 [monthly]

    Completed PHASE2

  4. Dec 2023 — Jun 2024 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  5. May 2023 — Dec 2023 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

▶ Show 12 earlier versions

  1. Feb 2023 — May 2023 [monthly]

    Recruiting PHASE2

  2. May 2022 — Feb 2023 [monthly]

    Recruiting PHASE2

  3. Apr 2021 — May 2022 [monthly]

    Recruiting PHASE2

  4. Jan 2021 — Apr 2021 [monthly]

    Recruiting PHASE2

  5. Aug 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  6. Sep 2019 — Aug 2020 [monthly]

    Recruiting PHASE2

  7. Jun 2019 — Sep 2019 [monthly]

    Recruiting PHASE2

  8. Dec 2018 — Jun 2019 [monthly]

    Recruiting PHASE2

  9. Jun 2018 — Dec 2018 [monthly]

    Recruiting PHASE2

  10. Apr 2018 — Jun 2018 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  11. Feb 2018 — Apr 2018 [monthly]

    Not Yet Recruiting PHASE2

  12. Dec 2017 — Feb 2018 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Helixmith Co., Ltd.
  • National Institute on Aging (NIA)
  • Northwestern University
Data source: Northwestern University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations